 - All patients with relapsed diffuse large, immunoblastic, anaplastic, de novo transformation of follicular lymphoma, or classical Hodgkins lymphoma which is CD20 antigen positive disease who have 2 of following risk factors: LDH upper limit of normal, KPS 80, Stage III or IV disease. 